Search

Displaying results 6371 - 6380 of 9670 in total
  1. Drug

    Garcinia gummi-gutta fruit

    go.drugbank.com/drugs/DB14365
    Investigational

    It is not an approved drug.

  2. Drug

    Rinucumab

    go.drugbank.com/drugs/DB16313
    Investigational

    Rinucumab is under investigation in clinical trial NCT02418754 (Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-related Macular Degeneration (AMD)).

  3. Drug

    BNT111

    go.drugbank.com/drugs/DB18177
    Investigational

    It consists of a fixed combination of mRNA-encoded, tumor-associated antigens.

  4. Drug

    Davanat

    go.drugbank.com/drugs/DB15311
    Investigational

    Davanat is under investigation in clinical trial NCT00054977 (Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors).

  5. Drug

    IGN101

    go.drugbank.com/drugs/DB06500
    Experimental

    It consists of 500 ug 17-1A antibody adsorbed on aluminum hydroxide.

  6. Drug

    BTA9881

    go.drugbank.com/drugs/DB05226
    Investigational

    It is currently in phase I trials.

  7. Drug

    Tyropanoic acid

    go.drugbank.com/drugs/DB09340
    Approved

    The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones, which results in a visible image [L1608].

  8. Drug

    Empasiprubart

    go.drugbank.com/drugs/DB16469
    Investigational

    Empasiprubart is a humanized sweeping antibody designed to bind to C2, a protein in the complement cascade that leads to cell destruction when activated.

  9. Drug

    E-6201

    go.drugbank.com/drugs/DB11687
    Investigational

    E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.

  10. Drug

    Tegobuvir

    go.drugbank.com/drugs/DB11852
    Investigational

    Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.